| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Lyell Immunopharma, Inc.
13G
LYEL · 55083R203
|
6.7% |
4/21/2026
Event 3/6/2026
|
||||
| Euler Fund, L.P. | 6.7% | |||||
| Euler Managers Limited | 6.7% | |||||
| Antonis Indianos | 6.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.